SCHEMBL3482696

SCHEMBL3482696

O=C1C=CC(=O)N1CCCCCCCCO

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 9/20 0.77
FAAH O00519 5/20 0.77
ALDH1A1 P00352 4/20 0.77
LMNA P02545 3/20 0.77
HTT P42858 2/20 0.77
RECQL P46063 2/20 0.77
RAB9A P51151 2/20 0.77
SMN1; SMN2 Q16637 2/20 0.77
MAPK1 P28482 2/20 0.77
MAPT P10636 2/20 0.77
NPSR1 Q6W5P4 2/20 0.77
HSP90AA1 P07900 1/20 0.77
TLR9 Q9NR96 1/20 0.77
TP53 P04637 1/20 0.77
PKM P14618 1/20 0.77
HPGD P15428 1/20 0.77
XBP1 P17861 1/20 0.77
GPR35 Q9HC97 1/20 0.77
GPR55 Q9Y2T6 1/20 0.77
PTGS1 P23219 7/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19084204 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAHTT
SCHEMBL3482486 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAHTT
SCHEMBL3482661 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAHTT
SCHEMBL307564 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAHTT
SCHEMBL2607936 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAHTT
SCHEMBL3482524 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAHTT
SCHEMBL19085941 1.00 MGLL (0.77) MGLLFAAHALDH1A1LMNAHTT
SCHEMBL3483054 0.98 MGLL (0.76) MGLLFAAHALDH1A1LMNAHTT
SCHEMBL1554093 0.91 MGLL (0.71) MGLLFAAHALDH1A1LMNAHTT
SCHEMBL20351983 0.88 MGLL (1.00) MGLLFAAHALDH1A1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158141-A1 Conjugates of Biomolecule and Use Thereof YAFEI SHANGHAI BIOLOG MEDICINE SCIENCE & TECHNOLOG (CN) 2023-05-25 US disclosed
US-20230158141-A1 Conjugates of Biomolecule and Use Thereof YAFEI SHANGHAI BIOLOG MEDICINE SCIENCE & TECHNOLOG (CN) 2023-05-25 US disclosed
US-11316118-B2 Dibenzo[d,B]silole-based reactive mesogens LOMOX LIMITED (GB) 2022-04-26 US disclosed
US-20190280223-A1 DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS LOMOX LIMITED (GB) 2019-09-12 US disclosed
US-20170033290-A1 FLUOROALKYLFLUORENE DERIVATIVES LOMOX LIMITED (GB) 2017-02-02 US disclosed
US-8420764-B2 Compound having silsesquioxane skeleton and its polymer JNC CORPORATION (JP) 2013-04-16 US disclosed
US-8236917-B2 Compound having silsesquioxane skeleton and its polymer JNC CORPORATION (JP) 2012-08-07 US disclosed
US-20120178894-A1 COMPOUND HAVING SILSESQUIOXANE SKELETON AND ITS POLYMER INAGAKI JYUN-ICHI (JP) 2012-07-12 US disclosed
US-20100240855-A1 Compound having silsesquioxane skeleton and its polymer JNC CORPORATION (JP) 2010-09-23 US disclosed
US-7705105-B2 A cyclic polymer of silsesquioxane skeleton with side chains formed byhydrosilation of an unsaturated end group containing an active polymerfunctional group; polyimidesiloxane copolymers; polyestersiloxane copolymers; high molecular weight; thin films; strength; heat resistance;waterproofing; CHISSO PETROCHEMICAL CORPORATION (JP) 2010-04-27 US disclosed
US-20070190344-A1 Verification of translation JNC CORPORATION (JP) 2007-08-16 US disclosed
US-20050009982-A1 Compound having silsesquioxane skeleton and its polymer CHISSO CORPORATION (JP) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190280223-A1 DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS CCNB1, CCNE2, UBE2G2 MGLL 1656/4885FAAH 1261/4885ALDH1A1 107/4885
US-11316118-B2 Dibenzo[d,B]silole-based reactive mesogens CCNB1, CCNE2, UBE2G2 MGLL 1656/4885FAAH 1261/4885ALDH1A1 107/4885
US-20170033290-A1 FLUOROALKYLFLUORENE DERIVATIVES FLNB, AFF2, EFHD2 MGLL 2677/4885FAAH 1067/4885ALDH1A1 88/4885
US-20230158141-A1 Conjugates of Biomolecule and Use Thereof CD47, FCGR2A, CD40 MGLL 2474/4885FAAH 2216/4885ALDH1A1 2422/4885
US-20050009982-A1 Compound having silsesquioxane skeleton and its polymer C1S, H1-4, H1-0 MGLL 4700/4885FAAH 4471/4885ALDH1A1 1780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.